New developments in septic acute kidney injury

Physiological Research

Volumn 59, Issue 6, 2010, Pages 859-869

  Chvojka, J ^a   Sykora R ^a   Karvunidis, T ^a   Radej J ^a   Krouzecky A ^a   Novak I ^a   Matejovic M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acute kidney injury; Pathophysiology; Proteomics; Sepsis

Indexed keywords

NITRIC OXIDE;

ACUTE KIDNEY FAILURE; ANIMAL; APOPTOSIS; HUMAN; INFLAMMATION; KIDNEY CIRCULATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEOMICS; REVIEW; SEPTIC SHOCK;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; HUMANS; INFLAMMATION; NITRIC OXIDE; PROTEOMICS; RENAL CIRCULATION; SHOCK, SEPTIC;

EID: 78651459973     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. ABUELO JG: Normotensive ischemic acute renal failure. N Engl J Med 357: 797-805, 2007.
2. ANGUS DC, LINDE-ZWIRBLE WT, LIDICKER J, CLERMONT G, CARCILLO J, PINSKY MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
3. BAUD L, OUDINET JP, BENS M, NOE L, PERALDI MN, RONDEAU E, ETIENNE J, ARDAILLOU R: Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 35: 1111-1118, 1989.
4. BOLISETTY S, AGARWAL A: Neutrophils in acute kidney injury: not neutral any more. Kidney Int 75: 674-676, 2009.
5. BOS EM, LEUVENINK HG, SNIJDER PM, KLOOSTERHUIS NJ, HILLEBRANDS JL, LEEMANS JC, FLORQUIN S, VAN GOOR H: Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 20: 1901-1905, 2009.
6. BROOKS C, WEI Q, CHO SG, DONG Z: Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 119: 1275-1285, 2009.
7. CHAWLA LS, SENEFF MG, NELSON DR, WILLIAMS M, LEVY H, KIMMEL PL, MACIAS WL: Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin J Am Soc Nephrol 2: 22-30, 2007.
8. CHERTOW GM, BURDICK E, HONOUR M, BONVENTRE JV, BATES DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370, 2005.
9. CHERTOW GM, SOROKO SH, PAGANINI EP, CHO KC, HIMMELFARB J, IKIZLER TA, MEHTA RL: Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int 70: 1120-1126, 2006.
10. CHVOJKA J, SÝKORA R, KROUŽECKÝ A, RADŽJ J, VARNEROVÁ V, KARVUNIDIS T, HES O, NOVÁK I, RADERMACHER P, MATĚJOVIČ M: Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs. Crit Care 12: R164, 2008.
11. COHEN J, CARLET J: INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 24: 1431-1440, 1996.
12. COHEN RI, HASSELL AM, MARZOUK K, MARINI C, LIU SF, SCHARF SM: Renal effects of nitric oxide in endotoxemia. Am J Respir Crit Care Med 164: 1890-1895, 2001.
13. CUNNINGHAM PN, DYANOV HM, PARK P, WANG J, NEWELL KA, QUIGG RJ: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168: 5817-5823, 2002.
14. CUNNINGHAM PN, WANG Y, GUO R, HE G, QUIGG RJ: Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172: 2629-2635, 2004.
15. DAMMAN K, VAN DEURSEN VM, NAVIS G, VOORS AA, VAN VELDHUISEN DJ, HILLEGE HL: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53: 582-588, 2009.
16. DEAR JW, YASUDA H, HU X, HIENY S, YUEN PS, HEWITT SM, SHER A, STAR RA: Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int 69: 832-836, 2006.
17. DEAR JW, LEELAHAVANICHKUL A, APONTE A, HU X, CONSTANT SL, HEWITT SM, YUEN PS, STAR RA: Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure. Crit Care Med 35: 2319-2328, 2007.
18. DE VRIESE AS, BOURGEOIS M: Pharmacologic treatment of acute renal failure in sepsis. Curr Opin Crit Care 9: 474-480, 2003.
19. DEVARAJAN P: Proteomics for the investigation of acute kidney injury. Contrib Nephrol 160: 1-16, 2008.
20. DI GIANTOMASSO D, MORIMATSU H, MAY CN, BELLOMO R: Intrarenal blood flow distribution in hyperdynamic septic shock: effect of norepinephrine. Crit Care Med 31: 2509-2513, 2003.
21. DOI K, LEELAHAVANICHKUL A, YUEN PS, STAR RA: Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119: 2868-2878, 2009.
22. FRIEDRICH JO, ADHIKARI N, HERRIDGE MS, BEYENE J: Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142: 510-524, 2005.
23. GORDON AC, RUSSELL JA, WALLEY KR, SINGER J, AYERS D, STORMS MM, HOLMES CL, HÉBERT PC, COOPER DJ, MEHTA S, GRANTON JT, COOK DJ, PRESNEILL JJ: The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 36: 83-91, 2010.
24. GULLICHSEN E, NELIMARKKA O, HALKOLA L, NIINIKOSKI J: Renal oxygenation in endotoxin shock in dogs. Crit Care Med 17: 547-550, 1989.
25. GUO R, WANG Y, MINTO AW, QUIGG RJ, CUNNINGHAM PN: Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 15: 3093-3102, 2004.
26. GUPTA A, RHODES GJ, BERG DT, GERLITZ B, MOLITORIS BA, GRINNELL BW: Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am J Physiol 293: F245-F254, 2007.
27. GUPTA A, GERLITZ B, RICHARDSON MA, BULL C, BERG DT, SYED S, GALBREATH EJ, SWANSON BA, JONES BE, GRINNELL BW: Distinct functions of activated protein C differentially attenuate acute kidney injury. J Am Soc Nephrol 20: 267-277, 2009.
28. HAUSER B, BRACHT H, MATEJOVIC M, RADERMACHER P, VENKATESH B: Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies. Anesth Analg 101: 488-498, 2005.
29. HEEMSKERK S, PICKKERS P, BOUW MP, DRAISMA A, VAN DER HOEVEN JG, PETERS WH, SMITS P, RUSSEL FG, MASEREEUW R: Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol 1: 853-862, 2006.
30. HEEMSKERK S, MASEREEUW R, RUSSEL FG, PICKKERS P: Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury. Nat Rev Nephrol 5: 629-640, 2009a.
31. HEEMSKERK S, MASEREEUW R, MOESKER O, BOUW MP, VAN DER HOEVEN JG, PETERS WH, RUSSEL FG, PICKKERS P: Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit Care Med 37: 417-423, 2009b.
32. HENGARTNER MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
33. HOLLY MK, DEAR JW, HU X, SCHECHTER AN, GLADWIN MT, HEWITT SM, YUEN PS, STAR RA: Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int 70: 496-506, 2006.
34. HORBELT M, LEE SY, MANG HE, KNIPE NL, SADO Y, KRIBBEN A, SUTTON TA: Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol 293: F688-F695, 2007.
35. HOTCHKISS RS, KARL IE: The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150, 2003.
36. HOTCHKISS RS, SWANSON PE, FREEMAN BD, TINSLEY KW, COBB JP, MATUSCHAK GM, BUCHMAN TG, KARL IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230-1251, 1999.
37. JOHANNES T, MIK EG, INCE C: Nonresuscitated endotoxemia induces microcirculatory hypoxic areas in the renal cortex in the rat. Shock 31: 97-103, 2009a.
38. JOHANNES T, MIK EG, KLINGEL K, GOEDHART PT, ZANKE C, NOHÉ B, DIETERICH HJ, UNERTL KE, INCE C: Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetised rats. Clin Exp Pharmacol Physiol 36: 870-879, 2009b.
39. KARVUNIDIS T, MAREŠ J, THONGBOONKERD V, MATĚJOVIČ M: Recent progress of proteomics in critical illness. Shock 31: 545-552, 2009.
40. KNOTEK M, ROGACHEV B, WANG W, ECDER T, MELNIKOV V, GENGARO PE, ESSON M, EDELSTEIN CL, DINARELLO CA, SCHRIER RW: Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59: 2243-2249, 2001.
41. LANGENBERG C, WAN L, EGI M, MAY CN, BELLOMO R: Renal blood flow in experimental septic acute renal failure. Kidney Int 69: 1996-2002, 2006a.
42. LANGENBERG C, BELLOMO R, MAY CN, EGI M, WAN L, MORGERA S: Renal vascular resistance in sepsis. Nephron Physiol 104: 1-11, 2006b.
43. LANGENBERG C, WAN L, EGI M, MAY CN, BELLOMO R: Renal blood flow and function during recovery from experimental septic acute kidney injury. Intensive Care Med 33: 1614-1618, 2007.
44. LANGENBERG C, BAGSHAW SM, MAY CN, BELLOMO R: The histopathology of septic acute kidney injury: a systematic review. Crit Care 12: R38, 2008.
45. LE DORZE M, LEGRAND M, PAYEN D, INCE C: The role of the microcirculation in acute kidney injury. Curr Opin Crit Care 15: 503-508, 2009.
46. LEROLLE M, NOCHY D, GUÉROT E, BRUNEVAL P, FAGON JY, DIEHL JL, HILL G: Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 36: 471-478, 2010.
47. LI L, HUANG L, SUNG SS, VERGIS AL, ROSIN DL, ROSE CE, JR, LOBO PI, OKUSA MD: The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 74: 1526-1537, 2008.
48. LI X, HASSOUN HT, SANTORA R, RABB H: Organ crosstalk: the role of the kidney. Curr Opin Crit Care 15: 481-487, 2009.
49. LIU KD, ALTMANN C, SMITS G, KRAWCZESKI CD, EDELSTEIN CL, DEVARAJAN P, FAUBEL S: Serum Interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care 13: R104, 2009.
50. LUGON JR, BOIM MA, RAMOS OL, AJZEN H, SCHOR N: Renal function and glomerular hemodynamics in male endotoxemic rats. Kidney Int 36: 570-575, 1989.
51. MACEDO E, MEHTA RL: Prerenal failure: from old concepts to new paradigms. Curr Opin Crit Care 15: 467-473, 2009.
52. MARIANO F, CANTALUPPI V, STELLA M, ROMANAZZI GM, ASSENZIO B, CAIRO M, BIANCONE L, TRIOLO G, RANIERI VM, CAMUSSI G: Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 12: R42, 2008.
53. MATĚJOVIČ M, KROUŽECKÝ A, MARTÍNKOVÁ V, ROKYTA R, JR, KRÁLOVÁ H, TRESKA V, RADERMACHER P, NOVÁK I: Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 21: 458-465, 2004.
54. MATĚJOVIČ M, KROUŽECKÝ A, MARTÍNKOVÁ V, ROKYTA R, JR, RADĚJ J, KRÁLOVÁ H, TRESKA V, RADERMACHER P, NOVÁK I: Effects of tempol, a free radical scavenger, on long-term hyperdynamic porcine bacteremia. Crit Care Med 33: 1057-1063, 2005.
55. MATĚJOVIČ M, RADERMACHER P, JOANNIDIS M: Acute kidney injury in sepsis: is renal blood flow more than just an innocent bystander? Intensive Care Med 33: 1498-1500, 2007
56. MAY C, WAN L, WILLIAMS J, WELLARD MR, PELL G, LANGENBERG C, JACKSON G, BELLOMO R: A technique for the simultaneous measurement of renal ATP, blood flow and pH in a large animal model of septic shock. Crit Care Resusc 9: 30-33, 2007.
57. MILLAR CG, THIEMERMANN C: Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br J Pharmacol 121: 1824-1830, 1997.
58. MESSMER UK, BRINER VA, PFEILSCHIFTER J: Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 55: 2322-2337, 1999.
59. MONGARDON N, DYSON A, SINGER M: Is MOF an outcome parameter or a transient, adaptive state in critical illness? Curr Opin Crit Care 15: 431-436, 2009
60. MULLENS W, ABRAHAMS Z, FRANCIS GS, SOKOS G, TAYLOR DO, STARLING RC, YOUNG JB, TANG WH: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 589-596, 2009.
61. VAN DER POLL T: Immunotherapy of sepsis. Lancet Infect Dis 1: 165-174, 2001.
62. PORTA F, TAKALA J, WEIKERT C, BRACHT H, KOLAROVA A, LAUTERBURG BH, BOROTTO E, JAKOB SM: Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function. Crit Care 10: R118, 2006.
63. RANGEL-FRAUSTO MS, PITTET D, COSTIGAN M, HWANG T, DAVIS CS, WENZEL RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273: 117-123, 1995.
64. RECTOR F, GOYAL S, ROSENBERG IK, LUCAS CE: Sepsis: a mechanism for vasodilatation in the kidney. Ann Surg 178: 222-226, 1973.
65. REINHART K, MEISNER M, BRUNKHORST FM: Markers for sepsis diagnosis: what is useful? Crit Care Clin 22: 503-519, ix-x, 2006
66. SAIKUMAR P, VENKATACHALAM MA: Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23: 511-521, 2003.
67. SCHRIER RW, WANG W: Acute renal failure and sepsis. N Engl J Med 351: 159-169, 2004.
68. SHARFUDDIN AA, SANDOVAL RM, BERG DT, MCDOUGAL GE, CAMPOS SB, PHILLIPS CL, JONES BE, GUPTA A, GRINNELL BW, MOLITORIS BA: Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol 20: 524-534, 2009.
69. SHEAR W, ROSNER MH: Acute kidney dysfunction secondary to the abdominal compartment syndrome. J Nephrol 19: 556-565, 2006.
70. SIMON F, GIUDICI R, SCHEUERLE A, GROGER M, ASFAR P, VOGT JA, WACHTER U, PLONER F, GEORGIEFF M, MOLLER P, LAPORTE R, RADERMACHER P, CALZIA E, HAUSER B: Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care 13: R113, 2009.
71. SINGER M: Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 35: S441-S448, 2007.
72. SINGER M, DE SANTIS V, VITALE D, JEFFCOATE W: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364: 545-548, 2004.
73. SMITH MP, BANKS RE, WOOD SL, LEWINGTON AJ, SELBY PJ: Application of proteomic analysis to the study of renal diseases. Nat Rev Nephrol 5: 701-712, 2009.
74. SUTTON TA: Alteration of microvascular permeability in acute kidney injury. Microvasc Res 77: 4-7, 2009.
75. TIWARI MM, BROCK RW, MEGYESI JK, KAUSHAL GP, MAYEUX PR: Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases. Am J Physiol 289: F1324-F1332, 2005.
76. THONGBOONKERD V, CHIANGJONG W, MARES J, MORAVEC J, TUMA Z, KARVUNIDIS T, SINCHAIKUL S, CHEN ST, OPATRNY K, MATEJOVIC M: Altered plasma proteome during an early phase of peritonitisinduced sepsis. Clin Sci 116: 721-730, 2009.
77. TRIPATARA P, PATEL NS, BRANCALEONE V, RENSHAW D, ROCHA J, SEPODES B, MOTA-FILIPE H, PERRETTI M, THIEMERMANN C: Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. Eur J Pharmacol 606: 205-209, 2009.
78. TRZECIAK S, DELLINGER RP, PARRILLO JE, GUGLIELMI M, BAJAJ J, ABATE NL, ARNOLD RC, COLILLA S, ZANOTTI S, HOLLENBERG SM: Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 49: 88-98, 2007.
79. WAGNER F, ASFAR P, CALZIA E, RADERMACHER P, SZABÓ C: Bench-to-bedside review: Hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care 13: 213, 2009.
80. VANHOREBEEK I, GUNST J, ELLGER B, BOUSSEMAERE M, LERUT E, DEBAVEYE Y, RABBANI N, THORNALLEY PJ, SCHETZ M, VAN DEN BERGHE G: Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney Int 76: 512-520, 2009.
81. WAN L, BAGSHAW SM, LANGENBERG C, SAOTOME T, MAY C, BELLOMO R: Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 36: S198-S203, 2008
82. WELTY-WOLF KE, CARRAWAY MS, ORTEL TL, GHIO AJ, IDELL S, EGAN J, ZHU X, JIAO JA, WONG HC, PIANTADOSI CA: Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol 290: L21-L31, 2006.
83. WU L, GOKDEN N, MAYEUX PR: Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol 18: 1807-1815, 2007a.
84. WU L, TIWARI MM, MESSER KJ, HOLTHOFF JH, GOKDEN N, BROCK RW, MAYEUX PR: Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol 292: F261-F268, 2007b.
85. WU X, GUO R, WANG Y, CUNNINGHAM PN: The role of ICAM-1 in endotoxin-induced acute renal failure. Am J Physiol 293: F1262-F1271, 2007.
86. YAMAGUCHI N, JESMIN S, ZAEDI S, SHIMOJO N, MAEDA S, GANDO S, KOYAMA A, MIYAUCHI T: Timedependent expression of renal vasoregulatory molecules in LPS-induced endotoxemia in rat. Peptides 27: 2258-2270, 2006.